Subsequent Parties; Limited Relationship. The Agreement shall inure to the benefit of and shall be binding upon the Parties hereto and their respective permitted successors, or assigns. Licensee shall not assign this Agreement (including by operation of law) without the written consent of Nasdaq. Nothing in the Agreement, express or implied, is intended to or shall (a) confer on any person other than the Parties hereto (and any of the Corporations), or their respective permitted successors or assigns, any rights to remedies under or by reason of this Agreement; (b) constitute the Parties hereto partners or participants in a joint venture; or (c) appoint one Party the agent of the other.
Subsequent Parties; Limited Relationship. This Agreement shall inure to the benefit of and shall be binding upon the parties hereto and their respective permitted successors or assigns. Neither party shall assign this Agreement (including by operation of law) without the prior written consent of the other party, such consent not to be unreasonably withheld. Notwithstanding the foregoing, OTC Markets Group may assign this Agreement to any successor or affiliate without the consent of the other party. Nothing in this Agreement, express or implied, is intended to or shall (a) confer on any person other than the parties hereto, or their respective permitted successors or assigns, any rights to remedies under or by reason of this Agreement; (b) constitute the parties hereto partners or participants in a joint venture; or (c) appoint one party the agent of the other.
Subsequent Parties; Limited Relationship. The Agreement shall inure to the benefit of and shall be binding upon the Parties hereto and their respective permitted successors or assigns. Neither Party shall assign this Agreement (including by operation of law) without the prior written consent of the other Party, such consent not to be unreasonably withheld. Nasdaq may, however, assign this Agreement to any subsidiary or affiliate without the consent of the Company. Nothing in this Agreement, express or implied, is intended to or shall (a) confer on any individual or entity other than the Parties hereto, or their respective permitted successors or assigns, any rights to remedies under or by reason of this Agreement; (b) constitute the Parties hereto partners or participants in a joint venture; or (c) appoint one Party the agent of the other. There are no third party beneficiaries of this Agreement except for Nasdaq, Nasdaq’s third party information providers that are indemnified hereunder, Fund families and trust sponsors using pricing agents and the persons indemnified under Section 15.
Subsequent Parties; Limited Relationship. Nothing in this Agreement, express or implied, is intended to or shall (a) confer on any Person other than the parties hereto, or their respective permitted successors or assigns, any rights to remedies under or by reason of this Agreement; (b) constitute the parties hereto partners or participants in a joint venture; or (c) appoint one party the agent of the other.
Subsequent Parties; Limited Relationship. The Agreement shall inure to the benefit of and shall be binding upon the parties hereto and their respective permitted successors, or assigns. Nothing in the Agreement, express or implied, is intended to or shall: (a) confer on any person other than the parties hereto, or their respective permitted successors or assigns, any rights to remedies under or by reason of this Agreement; (b) constitute the parties hereto partners or participants in a joint venture; or (c) appoint one party the agent of the other.
Subsequent Parties; Limited Relationship. This Agreement shall inure to the benefit of and shall be binding upon the Parties hereto and their respective permitted successors or assigns. Neither Party shall assign this Agreement (including by operation of law) without the prior written consent of the other Party, such consent not to be unreasonably withheld. Notwithstanding the foregoing, Nasdaq may, assign this Agreement, or any part of it, to any affiliated entity without the consent of the other Party. Nothing in this Agreement, express or implied, is intended to or shall:
Subsequent Parties; Limited Relationship. The Agreement shall inure to the benefit of and shall be binding upon the parties hereto and their respective permitted successors, or assigns. CME shall not assign this Agreement (including by operation of law) without the written consent of Nasdaq, which shall not unreasonably be withheld. Nothing in the Agreement, express or implied, is intended to or shall (a) confer on any person other than the parties hereto (and any of the Corporations), or their respective permitted successors or assigns, any rights to remedies under or by reason of this Agreement; (b) constitute the parties hereto partners or participants in a joint venture; or (c) appoint one party the agent of the other. Portions of this exhibit have been omitted pursuant to a request for confidential treatment filed with the Securities and Exchange Commission. The omissions have been indicated by asterisks (“*****”), and the omitted text has been filed separately with the Securities and Exchange Commission.
Subsequent Parties; Limited Relationship. The obligations under this Agreement shall inure to the benefit of and shall be binding upon the parties hereto and their respective permitted successors, or assigns. MCI shall not assign or transfer (including by operation of law) this Agreement without the prior written consent of Nasdaq. Nasdaq shall not assign this Agreement, without written consent of MCI, except to another of the Corporations. Nothing in this Agreement, express or implied, is intended to or shall (a) confer on any person other than the parties hereto (and any of the Corporations), or their respective permitted successors or assigns, any rights to remedies under or by reason of this Agreement; (b) constitute the parties hereto partners or participants in a joint venture; or (c) appoint one party the agent of the other. Nasdaq hereby consents to MCI's right to assign its right to that portion of the payments due under this Agreement which are allocable to the Separable Components (the "Component Payments") to the entity holding an ownership interest in the Separable Components (the "Assignee"), provided that, MCI shall remain liable for all its obligations not assigned hereunder. In the event that MCI or Nasdaq is in default under this Agreement or MCI is in default under its agreement with the Assignee and this Agreement is terminated, and Nasdaq has determined that it will retain use of the Separable Components under Section 18.4, then the Assignee may at any time direct Nasdaq by written Notice to make future Component Payments directly to such Assignee. Upon receipt of such Notice, Nasdaq shall thereafter make all Component Payments directly to the Assignee, at such location specified by the Assignee, free of any claim, counterclaim, recoupment, reduction, defense or offset with respect to MCI or any other person or entity other than Assignee, all of which Nasdaq hereby expressly waives with respect to Assignee, but reserves as to MCI. The Assignee shall not be entitled to recover from Nasdaq any payments made by Nasdaq to MCI in good faith before Nasdaq's receipt of the Assignee's Notice described herein. Upon assignment to a Corporation, Nasdaq shall notify MCI no later than 10 days following the assignment, cause such Corporation entity to expressly undertake, or by law undertake, Nasdaq's obligations (including those related to Components) to the extent of the assignment and deliver to MCI (within 15 days of delivery of the Notice of assignment to MCI) or its Assignee a guarant...
Subsequent Parties; Limited Relationship. The Agreement shall inure to the benefit of and shall be binding upon the Parties hereto and their respective permitted successors, or assigns. Licensee shall not assign this Agreement (including by operation of law) without the written Consent of Nasdaq, such Consent not to be unreasonably withheld, conditioned or delayed. Nothing in the Agreement, express or implied, is intended to or shall (a) confer on any person other than the Parties hereto (and any of the Corporations), or their respective permitted successors or assigns, any rights to remedies under or by reason of this Agreement; (b) constitute the Parties hereto partners or participants in a joint venture; or (c) appoint one Party the agent of the other.
Subsequent Parties; Limited Relationship. This Agreement shall inure to the benefit of and shall be binding upon the parties hereto and their respective permitted successors or assigns. Subscriber may not assign this Agreement (including by operation of law) without the prior written consent of NASDAQ OMX. NASDAQ OMX may assign this Agreement. Nothing in this Agreement, express or implied, is intended to or shall (a) confer on any individual or entity other than the parties hereto, or their respective permitted successors or assigns, any rights to remedies under or by reason of this Agreement; (b) constitute the parties hereto partners or participants in a joint venture; or (c) appoint one party the agent of the other. There are no third party beneficiaries of this Agreement except for NASDAQ OMX, NASDAQ OMX’s third party information providers and the persons indemnified under Section 12 above.
